Table 2:

Stroke characteristicsa

All Patients (n = 341)Endovascular Therapy (n = 133)IV tPA-Only (n = 61)No Reperfusion Therapy (n = 147)
Baseline NIHSS (median) (IQR)16 (13–21)16 (13–19)16 (12–22)17 (13–21)
FIV (mL) (median) (IQR)59.9 (17.1–129)27 (9.4–86.0)62.5 (8.7–118.7)93 (37.8–170.0)
Left hemisphere175 (51.3%)65 (48.9%)38 (62.3%)72 (48.9%)
Level of occlusion
    Extracranial ICA7 (2.0%)2 (1.5%)4 (6.6%)1 (0.6%)
    Tandem occlusion39 (11.4%)31 (23.3%)2 (3.3%)6 (4.1%)
    Intracranial ICA79 (23.2%)16 (12.0%)9 (14.8%)54 (36.7%)
    M1 division of MCA166 (48.7%)74 (55.6%)33 (54.1%)59 (40.1%)
    M2 division of MCA50 (14.7%)10 (7.5%)13 (21.3%)27 (18.4%)
PH114 (4.1%)3 (2.3%)8 (13.1%)4 (2.7%)
PH29 (2.6%)5 (3.8%)3 (4.9%)1 (0.7%)
ASPECTS (median) (IQR)Data unavailable8 (7–9)Data unavailableData unavailable
Wake-up strokeData unavailable19 (14.3%)Data unavailableData unavailable
Onset to treatment (min) (median) (IQR)310 (236–465)138 (115–155)
IA intubation5 (3.7%)
Recanalization (mTICI)
    mTICI 01 (0.8%)
    mTICI 11 (0.8%)
    mTICI 2a4 (3.0%)
    mTICI 2b91 (68.7%)
    mTICI 336 (26.9%)
  • Note:—IA indicates intra-arterial (ie, endovascular treatment).

  • a Values represent total number and percentage unless otherwise indicated.